Table 1.
Clinical characteristics of all patients.
| Number of patients | 120 |
|---|---|
| Age, years | 72 ± 11 |
| Gender (M/F) | 83/37 |
| Atrial fibrillation, n (%) | 74 (62) |
| Paroxysmal AF, n | 36 |
| Chronic AF, n | 38 |
| Hypertension, n (%) | 88 (73) |
| Diabetes mellitus, n (%) | 35 (29) |
| Dyslipidemia, n (%) | 58 (48) |
| Smokers, n (%) | 64 (53) |
| Chronic heart failure, n (%) | 35 (29) |
| Previous stroke, n (%) | 28 (23) |
| CHA2DS2VASc scorea | 3.7 ± 1.8 |
| NIHSS | 1.0 (0.5–3.0) |
| Medications | |
| Antiplatelet drugs, n (%) | 42 (35) |
| Anticoagulants, n (%) | 54 (45) |
| Warfarin, n | 46 |
| Dabigatran, n | 8 |
| NINDS clinical categories | |
| Cardioembolic stroke, n (%) | 53 (44) |
| Atherothrombotic stroke, n (%) | 20 (17) |
| Lacunar stroke, n (%) | 14 (12) |
| Other or undetermined, n (%) | 33 (28) |
AF, atrial fibrillation; NIHSS, National Institute of Health Stroke Scale.
Data are expressed as mean ± SD, number (percentage) of subjects or median (interquartile range).
a
CHA2DS2VASc score before onset of acute ischemic stroke.